The burden of chronic obstructive pulmonary disease (COPD) has grown over the last several decades, particularly in specific populations such as women and individuals living in rural areas. COPD is not simply a “smoker’s cough” but an underdiagnosed, life-threatening lung disease. A multitude of factors must be considered when selecting the most appropriate inhaled medication for each patient with COPD. These factors include the patient’s ability to use the device properly, the need for multiple inhaled medications, convenience, patient preferences, clinical evidence, symptom burden, and exacerbation risk. In light of the numerous options available for maintenance therapy for patients with COPD, choosing the most appropriate treatment can be challenging. Moreover, the Global Initiative for Chronic Obstructive Lung Disease (GOLD) consistently updates management recommendations to reflect the latest advances and inform treatment selection. Despite these advances, the management of COPD remains inadequate. The Respiratory Education Hub has been developed to assist health care providers in the diagnosis and management of COPD with CME/CE certified activities from renowned experts in the field, animations that can be used as a teaching tool for team members and patients, and downloadable resources to use in practice.
Please join Dr. Han and Dr. Lee in part 3 of a CMEO Snack series on CRSwNP, as they discuss the pathophysiology of CRSwNP and safety and efficacy data for biologics targeting type 2 inflammation and individualizing treatment.
In part 2 of this CMEO Snack series, join Dr. Han and Dr. Hopkins as they translate the updated guideline recommendations and discuss how to implement the suggestions into clinically meaningful changes in practice. Translation of the guidance by experts in the field will assist in a better understanding and application of the guidance to clinical practice.
In part one of this CMEO Snack series on CRSwNP, join Dr. Han and Dr. Lee as they discuss strategies for how clinicians can better recognize and understand the impact of the burden posed by CRSwNP.
This CME Outfitters podcast will present a patient case that shows how pharmacists can talk to patients presenting with cough, including recommending cough products, discussions about cough hypersensitivity syndrome, and facilitating patients who may have chronic cough to the next steps.
Every two and a half minutes, someone receives a diagnosis of lung cancer in the United States. Each day, nearly 400 people succumb to lung cancer. While the survival rate for lung cancer—the leading cause of cancer mortality—has markedly increased over the past 5 years, gaps in early diagnosis, treatment options and access, survival rate, and more remain for underserved populations, including those of varying racial and ethnic groups. A culmination of biases, disparities, and inequities continues a cycle of inadequate oncological treatment for lung cancer, thus resulting in delayed diagnosis, clinical management and treatment, prognosis, and survival rate.